Bearded Dragon Drug Dosing: Vet Reference Guide

Last reviewed: April 29, 2026 · ExoticRx Editorial

Bearded dragons (Pogona vitticeps) are now one of the most common reptile patients in companion-animal practice — and one of the most consistently under-served by general veterinary references. Most drug handbooks lean heavily on canine and feline data and either omit bearded-dragon dosing entirely or relegate it to a one-line footnote. This guide collects the dosing patterns we see most often across the peer-reviewed literature, with explicit citations on the drug pages themselves and an emphasis on how reptile physiology should change the way you reach for a particular drug.

ExoticRx currently surfaces 189 active dose rules for bearded dragons across antibiotics, antiparasitics, analgesics, anti-fungals, anesthetics, and supportive-care medications. Browse the full bearded-dragon formulary for the live data with citations and evidence levels.

Why bearded dragon dosing is not just "scaled-down dog dosing"

Three physiological points should anchor every reptile dosing decision. None of them are unique to bearded dragons, but all of them are easy to forget when the patient on the table looks deceptively like a small mammal:

• Ectothermy and thermal physiology. Drug metabolism in reptiles is temperature-dependent. A bearded dragon held at the low end of its preferred optimum temperature zone (POTZ, ~30–40 °C basking with cooler retreat) will clear most drugs more slowly than one held at the upper end. Always confirm husbandry before adjusting dose; under-housed patients are not under-dosed patients.
• Renal portal system. Hindlimb injections may pass first through the kidneys before reaching the systemic circulation. For nephrotoxic drugs (notably aminoglycosides — see Amikacin) and for drugs cleared substantially by the kidneys, prefer forelimb or cranial injection sites.
• Slow GI transit and feed-cycle dependence. Oral drugs are absorbed more slowly than in mammals, especially in recently fed dragons. Many oral antibiotic protocols in reptile medicine (e.g. Azithromycin) deliberately use longer dosing intervals — q48–72h is common, not unusual.

Antibiotic dosing notes

Most evidence-based reptile antibiotic protocols are extrapolated from either species-specific PK studies (where they exist) or from related chelonian / squamate work. The drugs we see most often dosed in bearded dragons:

• Amikacin — broad-spectrum aminoglycoside, used for gram-negative coverage including Pseudomonas. Nephrotoxic and ototoxic; reptiles are particularly sensitive. Pre-treatment hydration and forelimb IM administration on a q48–72h interval are standard. Always consider drug levels for prolonged courses.
• Amoxicillin — used PO q12–24h. Less commonly first-line in reptiles than in dogs/cats because most reptile clinical infections are gram-negative, but useful where culture and sensitivity guides it.
• Azithromycin — favoured for its long tissue half-life. Bearded-dragon protocols typically use PO q48–72h, an interval that comes directly from reptile-specific PK work; do not transplant a once-daily mammalian schedule.
• Ceftiofur and other third-generation cephalosporins — common where injectable gram-negative coverage is needed and aminoglycosides are contraindicated.

Antiparasitic dosing notes

Parasitism — particularly Oxyurids, Coccidia (including the highly pathogenic Isospora amphiboluri), and Cryptosporidium — is endemic in pet bearded dragons. Common dosing categories:

• Albendazole and Fenbendazole — benzimidazoles. Note that fenbendazole has been linked to heteropenia and bone-marrow suppression in some reptile patients; the published recommendation in many reptile sources is to use the lowest effective course rather than a long prophylactic regimen.
• Ponazuril / Toltrazuril — first-line for coccidiosis. PO regimens vary; check the drug pages for the specific source-cited dose.
• Metronidazole — for protozoal disease. Hepatotoxic at high cumulative doses; some reptile sources recommend lower per-dose levels and longer intervals than the mammalian standard. Always cross-check the species-specific entry in the formulary.

Analgesia and anesthesia

Pain assessment in reptiles is famously difficult, but the literature on opioid receptor distribution and behavioural pain scoring has matured significantly. Avoid the assumption that a reptile that is not vocalising is not in pain. Drugs we see used most often:

• Buprenorphine — partial mu-agonist. Variable efficacy across reptile species; bearded-dragon-specific PK work is limited, so clinical response should guide dosing intervals more than published mammalian extrapolations.
• Butorphanol — kappa-agonist; widely used in reptile sedation protocols despite mixed evidence on standalone analgesic efficacy in lizards. Often combined with an alpha-2 agonist for procedural sedation.
• Alfaxalone — neurosteroid anesthetic with a wide safety margin; the most commonly used induction agent in bearded dragons. IV ventral tail vein administration produces a faster, smoother induction than IM, but IM is acceptable in fractious patients.
• Atipamezole — alpha-2 antagonist for medetomidine / dexmedetomidine reversal. Standard equal-volume reversal applies.

Supportive care

Many bearded dragons present with husbandry-driven disease — secondary metabolic bone disease (NSHP), dehydration, anorexia — rather than a primary infectious or neoplastic process. Supportive-care drugs often outweigh the targeted therapy in clinical impact:

• Calcium (oral/injectable) — central to NSHP management. Oral calcium glubionate is most common at home; injectable calcium gluconate is reserved for acute hypocalcaemic crisis with tetany or seizure activity.
• Allopurinol — for visceral or articular gout; under-recognised in older bearded dragons.
• Acetylcysteine — nebulised mucolytic for respiratory disease, used adjunctively alongside systemic antibiotics where indicated.

Common dosing mistakes

1. Using the wrong weight unit. A 35 g hatchling and a 600 g adult differ by more than an order of magnitude. Always weigh on a gram-resolution scale and dose in mg/kg, not mg/g or whole tablets. The ExoticRx calculator handles g / kg / lbs conversion and concentration math for you.
2. Translating a canine interval directly. q12h dosing on a reptile that the source actually specifies as q48–72h can produce subtherapeutic peaks and unnecessary toxicity. Do not shorten reptile intervals without species-specific evidence.
3. Ignoring the renal portal system. See above; for nephrotoxic drugs, never default to a hindlimb site.
4. Dosing a cold animal. Husbandry first. A bearded dragon outside its POTZ will not respond predictably to even a well-chosen drug. Confirm enclosure temperatures before reaching for the prescription pad.

Sources

Dose ranges and recommendations on every drug page link back to one or more primary sources, including (but not limited to):

• Carpenter's Exotic Animal Formulary, current edition
• Mader's Reptile and Amphibian Medicine and Surgery
• BSAVA Manual of Reptiles
• Peer-reviewed PK and clinical literature in reptile medicine
• FDA Approved Animal Drug Products (the Green Book), where applicable

For full sources on a specific drug, open its drug page on ExoticRx — every entry shows its evidence level and citation alongside the dose range. To run weight-based math against any of the rules above, open the calculator and pick the bearded-dragon species entry.

Disclaimer

This article is an informational reference for licensed veterinary professionals, technicians, and students. It does not constitute veterinary medical advice and is not a substitute for clinical judgement, current peer-reviewed literature, or the recommendation of an attending clinician. See the full dosage disclaimer.